Japanese page
SCEJ

SCEJ 53rd Autumn Meeting (Nagano, 2022)

List of received applications (By topics code)


SY) SCEJ Division Symposium

SY-72. [Symposium of Division of Biochemical Engineering] New Trends of Biochemical Engineering for Post-corona Era <Live/Virtual>

Organizer(s): Nakano Hideo (Nagoya Univ.), Ueda Hiroshi (Tokyo Tech)

The new corona pandemic is finally coming to an end. However, it is certain that we will have to live with this corona in the future and that different pathogenic viruses will emerge again. In this symposium, we would like to discuss what biochemical engineering can contribute toward the future of post corona pandemic.

Most recent update: 2023-05-07 18:05:01

The keywords that frequently used
in this topics code.
KeywordsNumber
COVID-192
virus-like particle1

ACKN
No.
Title/Author(s)KeywordsStyle
50Development of a method to detect intracellular PPI using thrombopoietin receptor
(NIBIOHN) *(Reg)Kawahara M., (U. Tokyo) Horikawa M.
protein-protein interaction
signal transduction
cell proliferation
O
120Converting antibodies to rapid-response SARS-CoV-2 homogeneous immunosensors via Quenchbody technology and crowding agent
(Tokyo Tech) *(Reg)Zhu Bo, (TMDU) Nosaka Nobuyuki, (Weifang Med. U.) Dong Jinhua, (Tokyo Tech) Kitaguchi Tetsuya, (TMDU) Koike Ryuji, Wakabayashi Kenji, (Tokyo Tech) (Reg)Ueda Hiroshi
Quenchbody
Immunosensor
SARS-CoV-2
O
207Development of a disposable sensor chip for real-time monitoring of vancomycin using molecularly imprinted electrode
(Shibaura Inst. Tech.) *(Reg)Yoshimi Yasuo, (Reg)Aaryashree, Hatano Akihiko, (Saitama Med. U.) Saito Ken-ichi
Molecularly Imprinted Polymer
vancomycin
Therapeutic drug monitoring
O
392[Invited lecture] Molecular biological characteristics of coronavirus
(Gunma U.) Kamitani Wataru
COVID-19
Corona Virus
pandemic
O
394[Invited lecture] Preparation of virus-like particles using silkworm and antigen display
(Shizuoka U.) Park Enoch
virus-like particle
silkworm
vaccine
O
414Acquisition and characterization of anti-SARS-CoV-2 Spike human monoclonal antibody from single B cells derived from COVID-19 infected patients using cell-free protein synthesis system.
(Nagoya U.) *(Reg)Nakano Hideo, Kihara Monami, Kato Teruyo, (Meijo U.) (Reg)Kojima Takaaki, (Tokyo Tech) (Reg)Ueda Hiroshi, (Nagoya U.) Hase Tetsunari, Ishii Makoto
COVID-19
human monoclonal antibody
cell-free protein synthesis
O

List of received applications (By topics code)

List of received applications
SCEJ 53rd Autumn Meeting (Nagano, 2022)

(C) 2023 The Society of Chemical Engineers, Japan. . All rights reserved.
Most recent update: 2023-05-07 18:05:01
For more information contact Organizing Committee, SCEJ 53rd Autumn Meeting (Nagano, 2022)
E-mail: inquiry-53fwww3.scej.org
This page was generated by easp 2.47; update.pl 2.37 (C)1999-2015 kawase